Guangdong Marubi Biotechnology Co., Ltd.
603983.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.67B
Close$
$-7.50
126.2% downside
Current Fair Value
126.2% downsideOvervalued by 126.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $11.67 Billion |
|---|---|
| Enterprise Value | $10.83 Billion |
| Dividend Yield | $0.50 (1.72%) |
| Earnings per Share | $0.62 |
| Beta | 0.1 |
| Outstanding Shares | 394,285,000 |
Return
| Return on Equity | 6.42% |
|---|---|
| Return on Assets | 4.68% |
| Return on Invested Capital | 4.84% |
Valuation & Multiples
| P/E Ratio | 54.06 |
|---|---|
| PEG | 725.42 |
| Price to Sales | 3.58 |
| Price to Book Ratio | 3.58 |
| Enterprise Value to Revenue | 3.23 |
| Enterprise Value to EBIT | 64.62 |
| Enterprise Value to Net Income | 49 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 28, 2026
EPS Estimate
$0.18
Average shareholder expectationRevenue Estimate
$964.00 M
Average shareholder expectationNext Earnings Call
Expected Date
October 31, 2026
EPS Estimate
$0.16
Average shareholder expectationRevenue Estimate
$716.10 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Guangdong Marubi Biotechnology Co., Ltd.
1,380 employees
CEO: Huaiqing Sun Established in 2002 and headquartered in Guangzhou, China, Guangdong Marubi Biotechnology Co., Ltd. specializes in a range of cosmetic products. While a key focus lies in providing eye care solutions across China, the company's activitie...